Bravura is “reconfiguring” its business … the stock crashes 55%!
Nick Sundich, November 3, 2022
It is not often you hear company management admitting their firm needs to be reconfigured, but that’s just what Bravura Solutions’ (ASX:BVS) management did this morning. Shareholders have punished the stock sending it down by more than 50%.
No time to do stock research, but you still want to invest?
Stocks Down Under Concierge gives you timely BUY and SELL alerts on ASX-listed stocks!
GET A 3-MONTH FREE TRIAL TO CONCIERGE TODAY
Bravura needs to be reconfigured
Bravura, a provider of software solutions for global financial institutions, had been undertaking a strategic review and provided shareholders with an interim update along with FY23 guidance. The company, using language you’d typically expect of external management consultants or short-seller firms, literally said,’ The business will be required to be reconfigured to scale our product across customers’.
While the review found that the company had solid foundations, the pace of change in the industry from a traditional services model to a technology solutions provider will require the company to realign itself to create “product discipline”. In other words, the company developed its products in every direction without much focus.
A soft FY23 expected
Adding insult to injury, Bravura announced a downgrade to analysts’ consensus forecasts. The company still expects modest revenue growth of $270-$275m (up from $266.7m in FY22), but expects EBITDA of $10-$15m and an NPAT between breakeven and a $5m loss. Considering it made $45.3m in EBITDA and a $25.7m NPAT last year, this would be an enormous drop. It also told shareholders it would suspend dividends until it had transitioned through the current reset.
The company said that the repositioning would return it to a stronger footing, but investors are not hanging around for that, sending shares down more than 50%. Bravura’s market capitalisation is barely a tenth of what it was in January 2020, prior to the Corona Crash.
No time to do stock research, but you still want to invest?
Stocks Down Under Concierge gives you timely BUY and SELL alerts on ASX-listed stocks!
GET A 3-MONTH FREE TRIAL TO CONCIERGE TODAY
No credit card needed and the trial expires automatically.
Blog Categories
Get Our Top 5 ASX Stocks for FY25
Recent Posts
The 2024 Pitt Street Research Life Sciences Conference is coming up! And you’re invited!
The Pitt Street Research Life Sciences Conference is happening on September 19, 2024! The Life Sciences sector in Australia and New…
Invion (ASX:IVX): Using Photodynamic Therapy to fight cancer
Unless you’re a professional dermatologist, you may not have ever heard of Photodynamic Therapy, let alone thought of it as…
Bio Gene Technology (ASX:BGT): Commercialising a new class of insecticides
Bio Gene Technology (ASX:BGT) ASX-listed AgTech company developing two compounds – Flavocide™ and Qcide™ – as insecticides. Investors may hear…